Annual EBITDA
-$112.53 M
-$7.76 M-7.40%
December 31, 2023
Summary
- As of February 26, 2025, CRBU annual EBITDA is -$112.53 million, with the most recent change of -$7.76 million (-7.40%) on December 31, 2023.
- During the last 3 years, CRBU annual EBITDA has fallen by -$77.33 million (-219.64%).
- CRBU annual EBITDA is now -272.47% below its all-time high of -$30.21 million, reached on December 31, 2019.
Performance
CRBU EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$37.06 M
+$5.58 M+13.09%
September 30, 2024
Summary
- As of February 26, 2025, CRBU quarterly EBITDA is -$37.06 million, with the most recent change of +$5.58 million (+13.09%) on September 30, 2024.
- Over the past year, CRBU quarterly EBITDA has dropped by -$24.01 million (-183.91%).
- CRBU quarterly EBITDA is now -2094.26% below its all-time high of -$1.69 million, reached on June 30, 2020.
Performance
CRBU Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$161.70 M
-$24.01 M-17.44%
September 30, 2024
Summary
- As of February 26, 2025, CRBU TTM EBITDA is -$161.70 million, with the most recent change of -$24.01 million (-17.44%) on September 30, 2024.
- Over the past year, CRBU TTM EBITDA has dropped by -$55.80 million (-52.69%).
- CRBU TTM EBITDA is now -1400.97% below its all-time high of -$10.77 million, reached on March 31, 2020.
Performance
CRBU TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRBU EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.4% | -183.9% | -52.7% |
| 3 y3 years | -219.6% | -183.9% | -52.7% |
| 5 y5 years | -272.5% | -183.9% | -52.7% |
CRBU EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.5% | at low | -183.9% | +18.2% | -140.7% | at low |
| 5 y | 5-year | -272.5% | at low | -2094.3% | +18.2% | -1401.0% | at low |
| alltime | all time | -272.5% | at low | -2094.3% | +18.2% | -1401.0% | at low |
Caribou Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$37.06 M(-13.1%) | -$161.70 M(+17.4%) |
| Jun 2024 | - | -$42.65 M(-5.8%) | -$137.69 M(+8.2%) |
| Mar 2024 | - | -$45.29 M(+23.4%) | -$127.30 M(+13.1%) |
| Dec 2023 | -$112.53 M(+7.4%) | -$36.70 M(+181.2%) | -$112.53 M(+6.3%) |
| Sep 2023 | - | -$13.05 M(-59.5%) | -$105.90 M(-11.0%) |
| Jun 2023 | - | -$32.25 M(+5.6%) | -$118.94 M(+3.6%) |
| Mar 2023 | - | -$30.53 M(+1.5%) | -$114.76 M(+9.5%) |
| Dec 2022 | -$104.78 M | -$30.07 M(+15.3%) | -$104.78 M(+10.5%) |
| Sep 2022 | - | -$26.09 M(-7.1%) | -$94.84 M(+8.9%) |
| Jun 2022 | - | -$28.07 M(+36.6%) | -$87.11 M(+16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$20.55 M(+2.1%) | -$74.77 M(+11.3%) |
| Dec 2021 | -$66.00 M(+87.4%) | -$20.13 M(+9.7%) | -$67.18 M(+8.6%) |
| Sep 2021 | - | -$18.36 M(+16.7%) | -$61.88 M(+20.3%) |
| Jun 2021 | - | -$15.73 M(+21.5%) | -$51.43 M(+37.6%) |
| Mar 2021 | - | -$12.95 M(-12.7%) | -$37.39 M(+6.2%) |
| Dec 2020 | -$35.21 M(+16.5%) | -$14.83 M(+87.4%) | -$35.21 M(+72.8%) |
| Sep 2020 | - | -$7.91 M(+368.6%) | -$20.38 M(+63.5%) |
| Jun 2020 | - | -$1.69 M(-84.3%) | -$12.46 M(+15.7%) |
| Mar 2020 | - | -$10.77 M | -$10.77 M |
| Dec 2019 | -$30.21 M | - | - |
FAQ
- What is Caribou Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Caribou Biosciences?
- What is Caribou Biosciences annual EBITDA year-on-year change?
- What is Caribou Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Caribou Biosciences?
- What is Caribou Biosciences quarterly EBITDA year-on-year change?
- What is Caribou Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Caribou Biosciences?
- What is Caribou Biosciences TTM EBITDA year-on-year change?
What is Caribou Biosciences annual EBITDA?
The current annual EBITDA of CRBU is -$112.53 M
What is the all time high annual EBITDA for Caribou Biosciences?
Caribou Biosciences all-time high annual EBITDA is -$30.21 M
What is Caribou Biosciences annual EBITDA year-on-year change?
Over the past year, CRBU annual EBITDA has changed by -$7.76 M (-7.40%)
What is Caribou Biosciences quarterly EBITDA?
The current quarterly EBITDA of CRBU is -$37.06 M
What is the all time high quarterly EBITDA for Caribou Biosciences?
Caribou Biosciences all-time high quarterly EBITDA is -$1.69 M
What is Caribou Biosciences quarterly EBITDA year-on-year change?
Over the past year, CRBU quarterly EBITDA has changed by -$24.01 M (-183.91%)
What is Caribou Biosciences TTM EBITDA?
The current TTM EBITDA of CRBU is -$161.70 M
What is the all time high TTM EBITDA for Caribou Biosciences?
Caribou Biosciences all-time high TTM EBITDA is -$10.77 M
What is Caribou Biosciences TTM EBITDA year-on-year change?
Over the past year, CRBU TTM EBITDA has changed by -$55.80 M (-52.69%)